Shield Therapeutics (STX) Competitors GBX 4.54 -0.06 (-1.30%) As of 08/8/2025 11:49 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock STX vs. ELX, TAO, APC, DGI, IDEA, ANCR, VLG, EAH, DNL, and PXSShould you be buying Shield Therapeutics stock or one of its competitors? The main competitors of Shield Therapeutics include El Oro (ELX), TAO Alpha (TAO), Apc Technology Group (APC), DG Innovate (DGI), Ideagen (IDEA), Animalcare Group (ANCR), Venture Life Group (VLG), ECO Animal Health Group (EAH), Diurnal Group (DNL), and Provexis (PXS). Shield Therapeutics vs. Its Competitors El Oro TAO Alpha Apc Technology Group DG Innovate Ideagen Animalcare Group Venture Life Group ECO Animal Health Group Diurnal Group Provexis El Oro (LON:ELX) and Shield Therapeutics (LON:STX) are both small-cap computer hardware companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends. Do institutionals & insiders hold more shares of ELX or STX? 11.9% of Shield Therapeutics shares are owned by institutional investors. 62.2% of Shield Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation and earnings, ELX or STX? El Oro has higher earnings, but lower revenue than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than El Oro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEl Oro-£7.25M0.00N/A-£2.50N/AShield Therapeutics£20.92M2.14-£36.28M-£3.88-1.17 Does the media favor ELX or STX? In the previous week, El Oro's average media sentiment score of 0.00 equaled Shield Therapeutics'average media sentiment score. Company Overall Sentiment El Oro Neutral Shield Therapeutics Neutral Is ELX or STX more profitable? El Oro has a net margin of 0.00% compared to Shield Therapeutics' net margin of -173.43%. El Oro's return on equity of 0.00% beat Shield Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets El OroN/A N/A N/A Shield Therapeutics -173.43%-470.50%-47.85% SummaryEl Oro and Shield Therapeutics tied by winning 4 of the 8 factors compared between the two stocks. Get Shield Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STX vs. The Competition Export to ExcelMetricShield TherapeuticsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£44.80M£2.18B£5.44B£3.07BDividend YieldN/A2.92%4.61%5.03%P/E Ratio-1.174.2729.76170.60Price / Sales2.14675.34449.12303,755.49Price / Cash6.3610.3536.4227.96Price / Book82.9610.708.184.52Net Income-£36.28M£21.15B£3.26B£5.90B7 Day Performance0.89%0.05%6.88%1.27%1 Month Performance58.63%3.26%1.00%3.66%1 Year Performance10.73%2.74%28.85%58.43% Shield Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STXShield TherapeuticsN/AGBX 4.54-1.3%N/A+27.5%£44.80M£20.92M-1.1740,000ELXEl OroN/AN/AN/AN/A£41.06M-£7.25M-26.001,122TAOTAO AlphaN/AGBX 7.10+31.5%N/A+2,084.6%£26.89MN/A-32.503Gap UpHigh Trading VolumeAPCApc Technology GroupN/AN/AN/AN/A£18.03M£19.20M19.75164,000DGIDG InnovateN/AN/AN/AN/A£1.90M£24.50K-1.25790Gap DownIDEAIdeagenN/AN/AN/AN/A£1.03B£75.28M17,450.009ANCRAnimalcare GroupN/AGBX 272+0.4%N/A-1.1%£186.49M£84.90M5.07220VLGVenture Life GroupN/AGBX 63.50-1.6%N/A+45.6%£80.92M£51.77M107.76165News CoverageEAHECO Animal Health Group3.6241 of 5 starsGBX 74.96+0.6%GBX 150+100.1%-25.1%£50.79M£89.44M48.46234News CoveragePositive NewsDNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133PXSProvexisN/AGBX 0.69-6.5%N/A+19.6%£16.19M£846.98K-26.164Gap Down Related Companies and Tools Related Companies ELX Competitors TAO Competitors APC Competitors DGI Competitors IDEA Competitors ANCR Competitors VLG Competitors EAH Competitors DNL Competitors PXS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:STX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shield Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Shield Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STX Stock Alerts